Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome

Archives of Neurology

Volumn 53, Issue 11, 1996, Pages 1162-1166

  Di Luca, Monica ^a   Pastorino, Lucia ^a   Cattabeni, Flaminio ^a   Zanardi, Raffaella ^a   Scarone, Silvio ^a   Racagni, Giorgio ^a   Smeraldi, Enrico ^a   Perez, Jorge ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BIOCHEMICAL MARKER; ISOPROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0029819924     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550110114019     Document Type: Article

References (35)

1. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984;122:1131-1135.
2. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol. 1985; 17:278-282.
3. Giaccone G, Tagliavini F, Linoli G, et al. Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett. 1989;97:232-238.
4. Selkoe OJ, Bell DS, Podlisny MB, Price DL, Cork LC. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science. 1987;235:873-877.
5. Weidemann A, Konig G, Bunke D, Fisher P, et al. Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989; 57:115-126.
6. Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature. 1987;325:733-736.
7. Kitaguchi N, Takahasni Y, Tokushima Y, Shiojiri S, Ito H. A novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 1988:331:530-532.
8. Ponte P, Gonzales-DeWhitt P, Schilling J, et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 1988;331: 525-527.
9. Tanzi RE, McClatchey AI, Lampert ED, Villa-Komaroff L, Gusella JF, Neve RL. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 1988;331:520-530.
10. De Sauvage F, Octave J-N. A novel mRNA of the A4 amyloid precursor gene coding for a possible secreted protein. Science. 1989;245:651-653.
11. Schlossmacher MG, Ostaszewski BL, Hecker LI, et al. Detection of distinct isoform patterns of the β-amyloid precursor protein in human platelets and lymphocytes. Neurobiol Aging. 1992;13:421-434.
12. Golde T, Estes S, Usiak M, Yankin L, Yankin S. Expression of β amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in AD using PCR. Neuron. 1990;4:253-267.
13. Selkoe DJ, Podlinsly MB, Joakim CL, et al. β-Amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A. 1988;85: 7341-7345.
14. de Lustig ES, Kohan S, Famulari AL, Dominguez RO, Serra JA. Peripheral markers and diagnostic criteria in Alzheimer's disease: critical evaluation. Rev Neurosci. 1994;5:213-224.
15. Gardella JE, Ghiso J, Gorgone GA, et al. Intact Alzheimer amyloid precursor protein (APP) is present in platelet membrane and is encoded by platelet mRNA. Biochem Biophys Res Commun. 1990;173:1292-1298.
16. Bush AI, Martins RN, Rumble B, et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem. 1990;265:15977-15983.
17. Gardella JE, Gorgone GA, Newman P, Frangione B, Gorevic PD. Characterization of Alzheimer amyloid precursor protein transcripts in platelets and megakaryocytes. Neurosci Lett. 1992;138:229-232.
18. Allen JS, Murphy GM Jr, Eny LF, et al. Alzheimer's disesae: β amyloid precursor protein mRNA expression in mononuclear blood cells. Neurosci Lett. 1991;132:109-112.
19. Cole GM, Galasko D, Shapiro IP, Saitoh T. Stimulated platelets release amyloid β-protein precursor. Biochem Biophys Res Commun. 1990;170:288-295.
20. Van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD. Protease nexin II (amyloid β protein precursor): a platelet α-granule protein. Science. 1990; 248:745-748.
21. Smith RP, Higuchi DA, Broze GJ Jr. Platelet coagulation factor Xla-inhibitor, a form of Alzheimer amyloid precursor protein. Science. 1990;248:1126-1128.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
24. Perez J, Zanardi R, Mori S, Gasperini M, Smeraldi E, Racagni G. Abnormalities of cAMP-dependent endogenous phosphorylation in platelets from patients with bipolar disorders. Am J Psychiatry. 1995;152:1204-1206.
25. Bradford MM. Rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 1976;72:248-254.
26. Carrol RT, Lust MR, Kim KS, Doyle PD, Emmerling MR. An age-related correlation between levels of β-amyloid precursor protein and β-amyloid in human cerebrospinal fluid. Biochem Biophys Res Comm. 1995;210:345-349.
27. Zubenko GS, Wusylko M, Cohen B, Boller F, Teply I. Family study of platelet membrane fluidity in Alzheimer's disease. Science. 1987;238:539-542.
28. Bush AI, Whyte S, Thomas LD, et al. AP abnormality of plasma amyloid protein precursor in Alzheimer's disease. Ann Neurol. 1992;32:57-65.
29. Rumble B, Retallack R, Hilbich C, et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med. 1989;320:1446-1452.
30. Lannfelt L, Basun H, Wahlund L-O, Rowe BA, Wagner SL. Decreased α-secretasecleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nat Med. 1995;1:829-832.
31. Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D. Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 1995;38:643-648.
32. Selkoe DJ. Molecular pathology of amyloidogenic proteins and the role of amyloidosis in Alzheimer's disease. Neurobiol Aging. 1989;10:387-395.
33. Perlmutter LS, Chang C. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res Bull. 1990;24:677-686.
34. Vanley CT, Anguilar MJ, Kleinhenz RT, Lagios MD. Cerebral amyloid angiopathy. Hum Pathol. 1981;12:609-616.
35. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol. 1988;25:50-56.